New Owner
Baxter International - Prism Pharmaceuticals
Baxter International acquires Prism Pharmaceuticals
Announced: April 18, 2011
Closed: May 12, 2011
Type: Acquisition
Disposition: Combined
Terms: Cash & Stock
Status: Complete
Amount: $ 338,000,000
